Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher in Biomarker Collaboration with Luxembourg Group

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it is working with the new Luxembourg Clinical Proteomics unit of the Public Research Centre for Health (CRP-Santé) on developing workflows that overcome current bottlenecks in biomarker discovery and assay development for clinical proteomics research.

The firm said that it will collaborate with Bruno Domon, who is the director of the new institute. Thermo Fisher said that it has collaborated with Domon since 2007, and such collaboration led to the development of the intelligent Selected Reaction Monitoring (iSRM) technology now incorporated within the Thermo Scientific TSQ family of triple quadrupole mass spectrometers.

Domon's CRP-Santé research group will use the recently introduced Thermo Scientific LTQ Orbitrap Velos hybrid mass spectrometer equipped with electron transfer dissociation (ETD) for its biomarker discovery efforts. Thermo Fisher said that the new instrument is more accurate, faster and more sensitive than older generation LTQ Orbitrap instruments.

"This collaboration provides a unique opportunity for the company to expand its role in the development of cutting-edge biomarker research tools and consolidate its presence within the EU," Ian Jardine, VP of global R&D for Thermo Fisher Scientific, said in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.